Home » Topics » BioWorld Science

BioWorld Science
RSS

Ribozyme treatment of HIV-1-infected patients

May 10, 1996

Saquinavir combinations under clinical evaluation

May 10, 1996

DuPont Merck discloses HIV protease inhibitors

May 10, 1996

Academic investigators report potential anti-HIV agents

May 10, 1996

U-31355: potent HIV-1 RTase inhibitor

May 10, 1996

Reticulose begins clinical testing for HPV indication

May 10, 1996

Sporanox-Pulse now available in U.K.

May 10, 1996

Vical/Merck DNA influenza vaccine moves ahead to clinical testing

May 10, 1996

Mentax clinical results in athlete's foot presented at conference

May 10, 1996

Supplemental NDA filing for Abelcet

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...